N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide

C102H123F3N20O11S5 — CID 161381671

IUPACN-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCC(O)CC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCOCC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)Cc4cccc(C(F)(F)F)c4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1
InChIInChI=1S/C27H28F3N5O2S.C26H31N5O3S2.C25H33N5O3S.C24H31N5O3S/c1-3-23(36)32-21-11-9-19(10-12-21)25(37)35-13-5-8-22(17-35)33-26-31-15-24(38-26)34(2)16-18-6-4-7-20(14-18)27(28,29)30;1-5-21(32)29-18-10-8-17(9-11-18)24(33)31-12-6-7-19(15-31)30-25-28-14-23(36-25)35-16-22-27-13-20(34-22)26(2,3)4;1-3-22(32)27-18-8-6-17(7-9-18)24(33)30-14-4-5-19(16-30)28-25-26-15-23(34-25)29(2)20-10-12-21(31)13-11-20;1-3-21(30)26-18-8-6-17(7-9-18)23(31)29-12-4-5-19(16-29)27-24-25-15-22(33-24)28(2)20-10-13-32-14-11-20/h3-4,6-7,9-12,14-15,22H,1,5,8,13,16-17H2,2H3,(H,31,33)(H,32,36);5,8-11,13-14,19H,1,6-7,12,15-16H2,2-4H3,(H,28,30)(H,29,32);3,6-9,15,19-21,31H,1,4-5,10-14,16H2,2H3,(H,26,28)(H,27,32);3,6-9,15,19-20H,1,4-5,10-14,16H2,2H3,(H,25,27)(H,26,30)/t22-;19-;19-,20?,21?;19-/m1011/s1
InChIKeyVRUNKTYTXWWWIU-UVPGVTFDSA-N
MW2022.56 g/mol
LogP18.53
Rot. Bonds30

About N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide

N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide (PubChem CID 161381671) has the molecular formula C102H123F3N20O11S5 and a molecular weight of 2022.56 g/mol. Its IUPAC name is N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide.

Molecular Properties

Compound NameN-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide
PubChem CID161381671
Molecular FormulaC102H123F3N20O11S5
Molecular Weight2022.56 g/mol
Exact Mass2020.82
IUPAC NameN-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCC(O)CC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCOCC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)Cc4cccc(C(F)(F)F)c4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1
InChIInChI=1S/C27H28F3N5O2S.C26H31N5O3S2.C25H33N5O3S.C24H31N5O3S/c1-3-23(36)32-21-11-9-19(10-12-21)25(37)35-13-5-8-22(17-35)33-26-31-15-24(38-26)34(2)16-18-6-4-7-20(14-18)27(28,29)30;1-5-21(32)29-18-10-8-17(9-11-18)24(33)31-12-6-7-19(15-31)30-25-28-14-23(36-25)35-16-22-27-13-20(34-22)26(2,3)4;1-3-22(32)27-18-8-6-17(7-9-18)24(33)30-14-4-5-19(16-30)28-25-26-15-23(34-25)29(2)20-10-12-21(31)13-11-20;1-3-21(30)26-18-8-6-17(7-9-18)23(31)29-12-4-5-19(16-29)27-24-25-15-22(33-24)28(2)20-10-13-32-14-11-20/h3-4,6-7,9-12,14-15,22H,1,5,8,13,16-17H2,2H3,(H,31,33)(H,32,36);5,8-11,13-14,19H,1,6-7,12,15-16H2,2-4H3,(H,28,30)(H,29,32);3,6-9,15,19-21,31H,1,4-5,10-14,16H2,2H3,(H,26,28)(H,27,32);3,6-9,15,19-20H,1,4-5,10-14,16H2,2H3,(H,25,27)(H,26,30)/t22-;19-;19-,20?,21?;19-/m1011/s1
InChIKeyVRUNKTYTXWWWIU-UVPGVTFDSA-N
XLogP18.53
TPSA362.53 Ų
H-Bond Donors9
H-Bond Acceptors28
Rotatable Bonds30
Heavy Atoms141
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002022.56
LogP ≤ 518.53
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide?
The IUPAC name of N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide (CID 161381671) is N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide.
What is the SMILES notation for N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide?
The canonical SMILES for N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide is C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCC(O)CC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)C4CCOCC4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(N(C)Cc4cccc(C(F)(F)F)c4)s3)C2)cc1.C=CC(=O)Nc1ccc(C(=O)N2CCC[C@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1.
What is the InChIKey of N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide?
The InChIKey is VRUNKTYTXWWWIU-UVPGVTFDSA-N. The full InChI is InChI=1S/C27H28F3N5O2S.C26H31N5O3S2.C25H33N5O3S.C24H31N5O3S/c1-3-23(36)32-21-11-9-19(10-12-21)25(37)35-13-5-8-22(17-35)33-26-31-15-24(38-26)34(2)16-18-6-4-7-20(14-18)27(28,29)30;1-5-21(32)29-18-10-8-17(9-11-18)24(33)31-12-6-7-19(15-31)30-25-28-14-23(36-25)35-16-22-27-13-20(34-22)26(2,3)4;1-3-22(32)27-18-8-6-17(7-9-18)24(33)30-14-4-5-19(16-30)28-25-26-15-23(34-25)29(2)20-10-12-21(31)13-11-20;1-3-21(30)26-18-8-6-17(7-9-18)23(31)29-12-4-5-19(16-29)27-24-25-15-22(33-24)28(2)20-10-13-32-14-11-20/h3-4,6-7,9-12,14-15,22H,1,5,8,13,16-17H2,2H3,(H,31,33)(H,32,36);5,8-11,13-14,19H,1,6-7,12,15-16H2,2-4H3,(H,28,30)(H,29,32);3,6-9,15,19-21,31H,1,4-5,10-14,16H2,2H3,(H,26,28)(H,27,32);3,6-9,15,19-20H,1,4-5,10-14,16H2,2H3,(H,25,27)(H,26,30)/t22-;19-;19-,20?,21?;19-/m1011/s1.
What are the key properties of N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide?
N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide has a molecular weight of 2022.56 g/mol, XLogP of 18.53, 30 rotatable bonds, 9 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[(3S)-3-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[(4-hydroxycyclohexyl)-methylamino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl(oxan-4-yl)amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide;N-[4-[(3R)-3-[[5-[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-1,3-thiazol-2-yl]amino]piperidine-1-carbonyl]phenyl]prop-2-enamide is sourced from PubChem (CID 161381671), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).